Rescue Studies

Clinical trials frequently encounter delays, with 80% failing to complete on schedule and 20% delayed by six months or more. Rescue studies have become vital for addressing such challenges, especially in complex therapeutic areas like oncology, solid tumors, rare diseases, first-in-human trials, and antibody-drug conjugates. Precision specializes in turning around struggling trials through four key pillars: reestablishing control, realigning the foundation, moving fast, and protecting data integrity. Their approach emphasizes consistent site management, streamlined global processes, clarified protocols, and improved data collection to restore stability. Accelerated site activation, contracting, and recruitment enable speed without sacrificing quality.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.